Search

Search Constraints

You searched for: Author/Creator Limdi, Jimmy

Search Results

1. ADTU-06 'real world' outcomes of vedolizumab over 12 months: the cross pennine multicentre experience. (8th June 2018)

2. Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study. (April 2021)

3. BSG 2024 IBD guidelines protocol (standard operating procedures). Issue 1 (10th February 2023)

4. Consensus standards of healthcare for adults and children with inflammatory bowel disease in the UK. Issue 3 (24th July 2019)

6. Effectiveness and Safety of Vedolizumab (VDZ) in IBD Patients: A Multicenter Experience of "Real World Data" From the U.K.: 688. (October 2017)

7. Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial. (February 2022)

8. Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study. (February 2022)